![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Emergence and Long-term Persistence of NS3, NS5A, and NS5B Resistance Associated Substitutions After Treatment With Direct-acting Antivirals
|
|
|
Reported by Jules Levin
Digestive Disease Week
02nd - 05th June, 2018 Washington, D.C
David L Wyles,1 Eric Lawitz,2 Nelson Cheinquer,3 Brian McNabb,3 Julia Lu,3 Silvia Chang,3 Anu Osinusi,3 Evguenia Svarovskaia,3 Diana Brainard,3 Stephen Pianko,4 Jordan J Feld,5 Hongmei Mo,3 Hadas Dvory-Sobol3
1Denver Health Medical Center, Denver, CO, USA; 2The University of Texas Health San Antonio, San Antonio, TX, USA; 3Gilead Sciences, Foster City, CA, USA; 4Monash Health and Monash University, Melbourne, VIC, Australia; 5Toronto Centre for Liver Disease; University Health Network, Toronto, ON, Canada
![0615181](../images%20/061518/061518-5/0615181.gif)
![0615182](../images%20/061518/061518-5/0615182.gif)
![0615183](../images%20/061518/061518-5/0615183.gif)
![0615184](../images%20/061518/061518-5/0615184.gif)
![0615185](../images%20/061518/061518-5/0615185.gif)
![0615186](../images%20/061518/061518-5/0615186.gif)
![0615187](../images%20/061518/061518-5/0615187.gif)
![0615188](../images%20/061518/061518-5/0615188.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|